Actieve functies van Charlie Qi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-08-2020 | - |
| Roche Global Product Development Center | Corporate Officer/Principal | 01-08-2017 | - |
Loopbaan van Charlie Qi
Eerdere bekende functies van Charlie Qi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01-05-2012 | 01-08-2017 |
Statistieken
Internationaal
| China | 3 |
| Kaaimaneilanden | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Roche Global Product Development Center |
- Beurs
- Insiders
- Charlie Qi
- Ervaring
